These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 21090937)

  • 1. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
    Cole JE; Mitra AT; Monaco C
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target.
    Liu Y; Yu H; Zhang Y; Zhao Y
    Med Hypotheses; 2008; 70(2):314-6. PubMed ID: 17689203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune signals in atherosclerosis.
    Lundberg AM; Hansson GK
    Clin Immunol; 2010 Jan; 134(1):5-24. PubMed ID: 19740706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential Roles of Toll-Like Receptors in Atherosclerosis.
    Lin J; Kakkar V; Lu X
    Curr Med Chem; 2016; 23(5):431-54. PubMed ID: 26639096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors as targets for immune disorders.
    Keogh B; Parker AE
    Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease: Toll-like receptors in cardiovascular disease.
    Frantz S; Ertl G; Bauersachs J
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):444-54. PubMed ID: 17653117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease.
    Ionita MG; Arslan F; de Kleijn DP; Pasterkamp G
    J Innate Immun; 2010; 2(4):307-15. PubMed ID: 20431283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of inflammatory cells and toll-like receptors in atherosclerosis.
    Seneviratne AN; Monaco C
    Curr Vasc Pharmacol; 2015; 13(2):146-60. PubMed ID: 24188491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors in inflammation of the central nervous system.
    Kong Y; Le Y
    Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
    Lin Q; Li M; Fang D; Fang J; Su SB
    Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Toll-like receptors signal: what we know and what we don't know.
    O'Neill LA
    Curr Opin Immunol; 2006 Feb; 18(1):3-9. PubMed ID: 16343886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications.
    McNeill E; Channon KM; Greaves DR
    Clin Sci (Lond); 2010 Mar; 118(11):641-55. PubMed ID: 20210786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity, macrophage activation, and atherosclerosis.
    Yan ZQ; Hansson GK
    Immunol Rev; 2007 Oct; 219():187-203. PubMed ID: 17850490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
    J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Toll-like receptors in liver health and disease.
    Broering R; Lu M; Schlaak JF
    Clin Sci (Lond); 2011 Nov; 121(10):415-26. PubMed ID: 21797822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.
    O'Neill LA
    Immunol Rev; 2008 Dec; 226():10-8. PubMed ID: 19161412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of toll-like receptors by insulin.
    Tilich M; Arora RR
    Am J Ther; 2011 Sep; 18(5):e130-7. PubMed ID: 21326087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.